Aspiriant LLC’s iShares MSCI Switzerland ETF EWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Buy
4,834
+254
+6% +$15.6K 0.01% 314
2026
Q1
$269K Sell
4,580
-323
-7% -$19.8K 0.01% 296
2025
Q4
$294K Buy
+4,903
New +$282K 0.01% 283
2016
Q3
Sell
-12,010
Closed -$393K 193
2016
Q2
$393K Buy
+12,010
New +$363K 0.04% 148

Other funds holding EWL

Aspiriant LLC's EWL Position: Q2 2026 in Review

Aspiriant LLC increased its iShares MSCI Switzerland ETF (EWL) stake by 5.5% in Q2 2026, buying an estimated $15.6K and bringing the position to 4,834 shares worth $304K. The position accounts for 0.01% of the portfolio, ranked #314.

Aspiriant LLC first reported a position in EWL in Q2 2016 and has held it in 4 quarters since. The position peaked at $393K in Q2 2016. 194 funds tracked by Wall St. Rank hold EWL as of Q2 2026.

  • Aspiriant LLC held 4,834 shares of iShares MSCI Switzerland ETF worth $304K as of Q2 2026.
  • Aspiriant LLC bought 254 iShares MSCI Switzerland ETF shares in Q2 2026, an estimated $15.6K.
  • iShares MSCI Switzerland ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #314 holding.
  • Aspiriant LLC first reported a position in iShares MSCI Switzerland ETF in Q2 2016 and has held it in 4 quarters since.
  • Aspiriant LLC's iShares MSCI Switzerland ETF position peaked at $393K in Q2 2016.
  • 194 funds tracked by Wall St. Rank held iShares MSCI Switzerland ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.